The Impact of a Human Breast Milk Supplement on Epigenetic and Cellular Markers
Clinical trial NCT05297097 · UNKNOWN
Trial details
- NCT number
- NCT05297097
- Sponsor
- TruDiagnostic
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2022-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.